Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1529, Issue 1-3, 2000, Pages 257-275

  Yamashita, Shizuya ^a   Hirano, Ken ichi ^a   Sakai, Naohiko ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Cholesteryl ester transfer protein deficiency; Hyperalphalipoproteinemia; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN B; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BINDING PROTEIN; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID TRANSFER PROTEIN; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN;

ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CORONARY ARTERY ATHEROSCLEROSIS; EXON; GENE MUTATION; HUMAN; HYPERALPHALIPOPROTEINEMIA; HYPERLIPOPROTEINEMIA; INTRON; JAPAN; LIPOPROTEIN METABOLISM; MISSENSE MUTATION; MOLECULAR BIOLOGY; MULTIGENE FAMILY; NONHUMAN; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; REGULATORY MECHANISM; REVIEW;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; BASE SEQUENCE; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; COHORT STUDIES; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; HYPERLIPOPROTEINEMIAS; LIPOPROTEINS, HDL; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034672713     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(00)00164-5     Document Type: Review

References (135)

1. High density lipoproteins as a protective factor against coronary heart disease
2. The plasma lecithin:cholesterol acyltransferase reaction
3. Molecular physiology of reverse cholesterol transport
4. Cell cholesterol efflux; integration of old and new observations provides new insights
5. High density lipoprotein receptors, binding proteins, and ligands
6. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux
7. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
8. Regulation of cholesteryl ester transfer protein (CETP) activity; review of in vitro and in vivo studies
9. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
10. Cloning and sequencing of human cholesteryl ester transfer protein cDNA
11. Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein
12. Molecular cloning, sequence, and expression of cynomolgus monkey cholesteryl ester transfer protein; inverse correlation between hepatic cholesteryl ester transfer protein mRNA levels and plasma high density lipoprotein levels
13. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA
14. Organization of the human cholesteryl ester transfer protein gene
15. Organization of human phospholipid transfer protein gene
16. Structure and function of the plasma phospholipid transfer protein
17. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells
18. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein
19. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution
20. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids
21. The CCAAT/enhancer-binding protein trans-activates the human cholesteryl ester transfer protein gene promoter
22. Plasma cholesteryl ester transfer protein
23. Analysis of cholesteryl ester transfer activity in adipose tissue
24. Cholesteryl ester transfer protein (CETP) mRNA abundance in human adipose tissue; relationship to cell size and membrane cholesterol content
25. Synthesis and secretion of plasma cholesteryl ester transfer protein by human hepatoma cell line, HepG2
26. Cholesteryl ester transfer protein is secreted by HepG2 cells and contain asparagine-linked carbohydrate and sialic acid
27. Molecular cloning, sequence, and expression of cynomolgus monkey cholesteryl ester transfer protein; inverse correlation between hepatic cholesteryl ester transfer protein mRNA levels and plasma high density lipoprotein levels
28. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species
29. Regulation of LTP-I secretion from human monocyte-derived macrophages by differentiation and cholesterol accumulation in vitro
30. Human liposarcoma cell line, SW872, secretes cholesteryl ester transfer protein in response to cholesterol
31. Cholesteryl ester transfer protein in human brain
32. Increased lipid transfer activities in hyperlipidemic rabbit plasma
33. Atherogenic diet increases cholesteryl ester transfer protein mRNA levels in rabbit liver
34. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice; dependence on natural flanking sequences
35. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice
36. Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5'-distal sequences; cis-acting sequences mapped in transgenic mice
37. Single nucleotide resolution of sterol regulatory region in promoter for 3-hydroxy-3-methylglutaryl-coenzyme A reductase
38. Sterol regulatory element binding protein-1 activates the cholesteryl ester transfer protein gene in vivo but is not required for sterol up-regulation of gene expression
39. Regulation of macrophage apolipoprotein E gene expression by cholesterol
40. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1); evidence for sterol-dependent regulation in macrophages
41. An oxysterol signalling pathway mediated by the nuclear receptor LXRα
42. Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ
43. Activation of the orphan nuclear receptor LXR by oxysterols defines a new hormone response pathway
44. Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols
45. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
46. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins
47. Evidence that the nonparenchymal cells are the principal source of cholesteryl ester transfer protein in primates
48. Increased plasma cholesteryl ester transfer protein in obese subjects; a possible mechanism for the reduction of serum HDL cholesterol levels in obesity
49. Alternative splicing of the mRNA encoding the human cholesteryl ester transfer protein
50. Inhibition of the cellular secretion of cholesteryl ester transfer protein by a variant protein formed by alternative splicing of mRNA
51. Alternative splicing of human plasma cholesteryl ester transfer protein mRNA in Caco-2 cells and its modulation by oleic acid
52. Identification of a sequence within the C-terminal 26 amino acids of cholesteryl ester transfer protein responsible for binding a neutralizing antibody and necessary for neutral lipid transfer activity
53. Establishment of anti-human cholesteryl ester transfer protein monoclonal antibodies and radioimmunoassaying of the level of cholesteryl ester transfer protein in human plasma
54. Synthesis and secretion of wild-type and mutant human plasma cholesteryl ester transfer protein in baculovirus-transfected insect cells; the carboxyl-terminal region is required for both lipoprotein binding and catalysis of transfer
55. Point mutagenesis of carboxyl-terminal amino acids of cholesteryl ester transfer protein. Opposite faces of an amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody
56. Purification, microheterogeneity, and stability of human lipid transfer protein
57. Human plasma cholesteryl ester transfer protein consists of a mixture of two forms reflecting variable glycosylation at asparagine 341
58. Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure
59. The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein
60. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism; insights from studies with transgenic mice
61. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
62. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism; studies in transgenic mice
63. A mouse model with features of familial combined hyperlipidemia
64. Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans
65. Liver LDL receptor mRNA expression is decreased in human apo B/CETP double transgenic mice and is regulated by diet as well as the cytokine oncostatin M
66. Estrogen-mediated increases in LDL cholesterol and foam cell-containing lesions in human apo B100 x CETP transgenic mice
67. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene
68. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase
69. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
70. Longevity syndromes; familial hypobeta and familial hyperalphalipoproteinemia
71. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyper HDL2 cholesterolemia with abnormal cholesteryl ester transfer
72. Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity; a case report
73. Deficiency of serum cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia
74. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinemia
75. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity
76. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency
77. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency
78. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
79. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
80. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol
81. Large and cholesteryl ester-rich high density lipoproteins in cholesteryl ester transfer protein deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low density lipoproteins
82. Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency
83. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency
84. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency
85. Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency
86. Very high density lipoprotein (VHDL) induced by plasma cholesteryl ester transfer protein (CETP) have a potent anti-atherogenic function
87. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apo A-I) transgene
88. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein A-I
89. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
90. Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect
91. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation
92. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population
93. A missense mutation in the cholesteryl ester transfer protein gene with dominant effects on plasma high density lipoproteins
94. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects
95. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol
96. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA
97. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects
98. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection
99. Human plasma CETP deficiency; identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America
100. Mutations in cholesteryl ester transfer protein and hepatic lipase in a North American population
101. Deficiency of cholesteryl ester transfer protein. Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma
102. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins
103. Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits
104. Effects of antisense oligodeoxynucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits
105. Molecular biology of phospholipid transfer protein
106. Atherosclerotic disease in marked hyperalphalipoproteinemia; combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase
107. Molecular defect and atherogenicity in cholesteryl ester transfer protein deficiency
108. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL-CE by cells expressing scavenger receptor B-I
109. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan; marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity
110. Increased coronary heart disease in Japanese-American men with mutations in the cholesteryl ester transfer protein gene despite increased HDL levels
111. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology
112. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1
113. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus
114. An StuI RFLP at the human cholesteryl ester transfer protein (CETP) locus
115. EcoN I polymorphism in the human cholesteryl ester transfer protein (CETP) gene
116. Genetic variation in the cholesteryl ester transfer protein and apolipoprotein A-I genes and its relation to coronary heart disease in Sri Lankan population
117. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels
118. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors; associations between TaqI B RFLP in the CETP gene and smoking and obesity
119. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers
120. Heterogeneity at the CETP gene locus; influence on plasma CETP concentrations and HDL cholesterol levels
121. for the Regression Growth Evaluation Statin Study Group; the role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
122. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia
123. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group
124. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
125. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease
126. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia
127. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction
128. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors
129. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia
130. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels; role of Sp1/Sp3 in transcriptional regulation
131. R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity
132. Association of cholesteryl ester transfer protein - TaqI B polymorphism with variations in lipoprotein subclasses and coronary heart disease risk; the Framingham Study
133. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men